據報花旗強制要求美國員工接種新冠疫苗
外媒報道,花旗集團(C.US)以就業條件爲由,強制要求所有美國員工接種新冠疫苗,爲美國首間發佈類似要求的主要銀行。公司人事部主管Sara Wechter於社交網站發文指出,新冠肺炎疫情明顯地不會在短期內消失,由於銀行與政府有業務往來,因此有義務遵守政府的行政命令,要求爲政府合同工作的人接種疫苗,強制接種疫苗還可以讓銀行確保員工重回辦公室工作時的健康和安全。
此外,《彭博通訊社》引述花旗給員工的備忘錄顯示,該行要求員工在12月8日之前提交疫苗接種證明,遵守規定的員工將獲得200美元作爲獎勵。花旗將1月14日定爲工人上傳疫苗卡的最後截止日期,以便讓未接種疫苗的員工有更多時間接種疫苗。
據瞭解,美國其他大型銀行如美銀(BAC.US)及高盛(GS.US),均已要求員工進入辦公室時必須接種疫苗,但並未表示將解僱拒絕接種疫苗的員工。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.